Current perspectives on mesenchymal stromal cell therapy for graft versus host disease

por Kadri, Nadir, Amu, Sylvie, Iacobaeus, Ellen, Boberg, Erik, Le Blanc, Katarina
Publicado 2023

Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT

por Boberg, Erik, Iacobaeus, Ellen, Greenfield, Myrto Sklivanioti, Wang, Yanlu, Msghina, Mussie, Le Blanc, Katarina
Publicado 2021

Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation

por Boberg, Erik, Kadri, Nadir, Hagey, Daniel W., Schwieler, Lilly, El Andaloussi, Samir, Erhardt, Sophie, Iacobaeus, Ellen, Le Blanc, Katarina
Publicado 2023

Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study

por Iacobaeus, Ellen, Kadri, Nadir, Lefsihane, Katia, Boberg, Erik, Gavin, Caroline, Törnqvist Andrén, Anton, Lilja, Anders, Brundin, Lou, Blanc, Katarina Le
Publicado 2019

Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease—a gut feeling

por Gavin, Caroline, Boberg, Erik, Von Bahr, Lena, Bottai, Matteo, Andrén, Anton Törnqvist, Wernerson, Annika, Davies, Lindsay C., Sugars, Rachael V., Le Blanc, Katarina
Publicado 2019

Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study

por Boberg, Erik, von Bahr, Lena, Afram, Gabriel, Lindström, Carina, Ljungman, Per, Heldring, Nina, Petzelbauer, Peter, Garming Legert, Karin, Kadri, Nadir, Le Blanc, Katarina
Publicado 2020